We are live on ! Find out more
TBPH icon

Theravance Biopharma

173 hedge funds and large institutions have $813M invested in Theravance Biopharma in 2026 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 60 increasing their positions, 46 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 46

21% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 34

2% more funds holding

Funds holding: 169173 (+4)

0.58% less ownership

Funds ownership: 97.87%97.29% (-0.58%)

12% less capital invested

Capital invested by funds: $927M → $813M (-$114M)

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

93% less call options, than puts

Call options by funds: $847K | Put options by funds: $11.6M

Holders
173
Holders Change
+4
Holders Change %
+2.37%
% of All Funds
2.13%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.05%
New
41
Increased
60
Reduced
46
Closed
34
Calls
$847K
Puts
$11.6M
Net Calls
-$10.7M
Net Calls Change
-$13.3M
Name Holding Trade Value Shares
Change
Change in
Stake
CMBA
201
C.M. Bidwell & Associates
Hawaii
-$4.77K -255 Closed
Daiwa Securities Group
202
Daiwa Securities Group
Japan
-$2K -115 Closed
Jones Financial Companies
203
Jones Financial Companies
Missouri
-$1.87K -100 Closed
C
204
Covestor
United Kingdom
-$212 -12 -36%
AAP
205
Arax Advisory Partners
Colorado
-$112 -6 Closed
TWD
206
True Wealth Design
Ohio
-$38 -2 Closed